Abbott Laboratories (ABT)
NYSE: ABT · Real-Time Price · USD
106.20
+1.63 (1.56%)
At close: Oct 30, 2026, 4:00 PM EDT
105.90
-0.30 (-0.28%)
After-hours: Oct 30, 2026, 7:38 PM EDT

Abbott Laboratories Revenue

Abbott Laboratories had revenue of $13.01B in the quarter ending September 30, 2026, with 14.46% growth. This brings the company's total for the last twelve months to $48.23B, up 10.00% year-over-year. In the year 2025, Abbott Laboratories had annual revenue of $44.33B with 5.67% growth. That makes Abbott Laboratories the 266th largest company in the world by revenue and 99th in the United States.

Revenue (ttm)
$48.23B
Revenue Growth
+10.00%
P/S Ratio
3.81
Revenue / Employee
$395,320
Employees
122,000
Market Cap
183.77B

Revenue Chart

Revenue by Segment

By Segment

Chart
  • Medical Devices 21.39B 48.2%
  • Diagnostics 8.94B 20.2%
  • Nutritionals 8.45B 19.1%
  • Established Pharmaceutical Products 5.54B 12.5%
  • Other Segment 17.00M 0.0%

By Geography

Chart
  • All Other Countries 17.32B 39.1%
  • United States 17.13B 38.6%
  • Germany 2.76B 6.2%
  • China 1.91B 4.3%
  • India 1.87B 4.2%
  • Switzerland 1.87B 4.2%
  • Japan 1.48B 3.3%
Fiscal year ended Dec 31, 2025 See the full Abbott Laboratories breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202544.33B2.38B5.67%
Dec 31, 202441.95B1.84B4.59%
Dec 31, 202340.11B-3.54B-8.12%
Dec 31, 202243.65B578.00M1.34%
Dec 31, 202143.08B8.47B24.47%
Dec 31, 202034.61B2.70B8.48%
Dec 31, 201931.90B1.33B4.34%
Dec 31, 201830.58B3.19B11.64%
Dec 31, 201727.39B6.54B31.35%
Dec 31, 201620.85B448.00M2.20%
Dec 31, 201520.41B158.00M0.78%
Dec 31, 201420.25B590.00M3.00%
Dec 31, 201319.66B607.00M3.19%
Dec 31, 201219.05B-2.36B-11.01%
Dec 31, 201121.41B-13.76B-39.13%
Dec 31, 201035.17B4.40B14.31%
Dec 31, 200930.76B1.24B4.19%
Dec 31, 200829.53B3.61B13.94%
Dec 31, 200725.91B3.44B15.30%
Dec 31, 200622.48B138.51M0.62%
Dec 31, 200522.34B--